Literature DB >> 1473622

Immune intervention yes, but for what reason, for whom, when and how?

A Lernmark1.   

Abstract

Mesh：

Year:  1992        PMID： 1473622     DOI： 10.1007/bf02221688

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  22 in total

1.  The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies. The Immunology and Diabetes Workshops and Participating Laboratories.

Authors:  A Lernmark; J L Molenaar; W A van Beers; Y Yamaguchi; S Nagataki; J Ludvigsson; N K Maclaren
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

2.  In situ analysis of pancreatic islets in rats developing diabetes. Appearance of nonendocrine cells with surface MHC class II antigens and cytoplasmic insulin immunoreactivity.

Authors:  P A In't Veld; D G Pipeleers
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

3.  Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases.

Authors:  G Feutren; M J Mihatsch
Journal:  N Engl J Med       Date:  1992-06-18       Impact factor: 91.245

4.  Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells.

Authors:  D Lo; L C Burkly; G Widera; C Cowing; R A Flavell; R D Palmiter; R L Brinster
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

5.  Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease.

Authors:  J K Karjalainen
Journal:  Diabetes       Date:  1990-09       Impact factor: 9.461

6.  Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children.

Authors:  M Landin-Olsson; A Karlsson; G Dahlquist; L Blom; A Lernmark; G Sundkvist
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

7.  Evidence for initial involvement of macrophage in development of insulitis in NOD mice.

Authors:  K U Lee; K Amano; J W Yoon
Journal:  Diabetes       Date:  1988-07       Impact factor: 9.461

8.  Recurrence of disease in pancreas transplants.

Authors:  D E Sutherland; F C Goetz; R K Sibley
Journal:  Diabetes       Date:  1989-01       Impact factor: 9.461

9.  Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.

Authors:  E Bonifacio; P J Bingley; M Shattock; B M Dean; D Dunger; E A Gale; G F Bottazzo
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

10.  Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10.

Authors:  A E Karlsen; W A Hagopian; C E Grubin; S Dube; C M Disteche; D A Adler; H Bärmeier; S Mathewes; F J Grant; D Foster; Åke Lernmark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205
View more
  1 in total

1.  HLA-DRB1 alleles contribute to determining the prognosis of Japanese diabetes mellitus positive for antibodies to glutamate decarboxylase.

Authors:  M Fukui; K Nakano; N Nakamura; E Maruya; H Saji; H Obayashi; K Ohta; M Ohta; H Mori; S Kajiyama; S Wada; Y Kida; K Kosaka; M Deguchi; H Shigeta; Y Kitagawa; M Kondo
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.